Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 2, 2011, Pages 81-87

  Faas, Brigitte H W ^a   Cirigliano, Vincenzo ^b,c   Bui, The Hung ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b General Lab   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Interphase fluorescence in situ hybridisation (iFISH); Multiplex ligation dependent probe amplification (MLPA); Prenatal; Quantitative fluorescent polymerase chain reaction (QF PCR); Rapid targeted testing

Indexed keywords

ANEUPLOIDY; CHORION VILLUS; CHROMOSOME ANALYSIS; CHROMOSOME DISORDER; FLUORESCENCE ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MATERNAL CELL CONTAMINATION; MOSAICISM; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SEX CHROMOSOME;

ANEUPLOIDY; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 79951943190     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2011.01.003     Document Type: Review

References (54)

1. Nicolini U., Lalatta F., Natacci F., Curcio C., Bui T.H. The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration. Hum Reprod Update 2004, 10:541-548.
2. Shaffer L.G., Bui T.H. Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis. Am J Med Genet C Semin Med Genet 2007, 145C:87-98.
3. Cirigliano V., Sherlock J., Conway G., Quilter C., Rodeck C., Adinolfi M. Rapid detection of chromosomes X and Y aneuploidies by quantitative fluorescent PCR. Prenat Diagn 1999, 19:1099-1103.
4. Adinolfi M., Sherlock J., Cirigliano V., Pertl B. Prenatal screening of aneuploidies by quantitative fluorescent PCR. Community Genet 2000, 3:50-60.
5. Cirigliano V., Voglino G., Canadas M.P., et al. Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR. Assessment on 18,000 consecutive clinical samples. Mol Hum Reprod 2004, 10:839-846.
6. Cirigliano V., Voglino G., Adinolfi M. Non invasive screening and rapid QF-PCR assay can greatly reduce the need of cytogenetic analysis in prenatal diagnosis. Reprod Biomed 2005, 11:671-673.
7. Chang Y.M., Burgoyne L.A., Both K. Higher failures of amelogenin sex test in an Indian population group. J Forensic Sci 2003, 48:1309-1313.
8. Santos F.R., Pandya A., Tyler-Smith C. Reliability of DNA-based sex tests. Nat Genet 1998, 18:103.
9. Shadrach B., Commane M., Hren C., Warshawsky I. A rare mutation in the primer binding region of the amelogenin gene can interfere with gender identification. J Molec Diagn 2004, 6:401-405.
10. Schmidt W., Jenderny J., Hecher K., Hackeloer B.J., Kerber S., Kochhan L., et al. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Molec Hum Reprod 2000, 6:855-860.
11. Cirigliano V., Ejarque M., Canadas M.P., et al. Clinical application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidies. Molec Hum Reprod 2001, 7:1001-1006.
12. Cirigliano V., Voglino G., Ordoñez E., et al. Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR, results of 9 years of clinical experience. Prenat Diagn 2009, 29:40-49.
13. Mann K., Fox S.P., Abbs S.J., et al. Development and implementation of a new rapid aneuploidy diagnostic service within the UK national health service and implications for the future of prenatal diagnosis. Lancet 2001, 358:1057-1061.
14. Mann K., Donaghue C., Fox S.P., Docherty Z., Ogilvie C.M. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet 2004, 12:907-915.
15. Voglino G., Marongiu A., Massobrio M., Campogrande M., Todros T. Rapid prenatal diagnosis of aneuploidies. Lancet 2002, 359:442.
16. Bili C., Divane A., Apessos A., et al. Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR. Prenat Diagn 2002, 22:360-365.
17. Andonova S., Vazharova R., Dimitrova V., Mazneikova V., Toncheva D., Kremensky I. Introduction of the QF-PCR analysis for the purposes of prenatal diagnosis in Bulgaria, estimation of applicability of 6 STR markers on chromosomes 21 and 18. Prenat Diagn 2004, 24:202-208.
18. El Mouatassim S., Becker M., Kuzio S., et al. Prenatal diagnosis of common aneuploidies using multiplex quantitative fluorescent polymerase chain reaction. Fetal Diagn Ther 2004, 19:496-503.
19. Ogilvie C.M., Lashwood A., Chitty L., Waters J.J., Scriven P.N., Flinter F. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing. BJOG 2005, 112:1369-1375.
20. Brown L., Abigania M., Warburton D., Brown S. Validation of QF-PCR for prenatal aneuploidy screening in the United States. Prenat Diagn 2006, 26:1068-1074.
21. Ochshorn Y., Bar-Shira A., Jonish A., Yaron Y. Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, and X by quantitative fluorescence polymerase chain reaction. Fetal Diagn Ther 2006, 21:326-331.
22. Onay H., Ugurlu T., Aykut A., et al. Rapid prenatal diagnosis of common aneuploidies in amniotic fluid using quantitative fluorescent polymerase chain reaction. Gynecol Obstet Invest 2008, 66:104-110.
23. Putzova M., Soldatova I., Pecnova L., et al. QF-PCR-based prenatal detection of common aneuploidies in the Czech population: five years of experience. Eur J Med Genet 2008, 51:209-218.
24. Cho E.H., Park B.Y., Kang Y.S., Lee E.H. Validation of QF-PCR in a Korean population. Prenat Diagn 2009, 29:213-216.
25. Hills A., Donaghue C., Waters J., et al. QF-PCR as a stand-alone test for prenatal samples: the first 2 years' experience in the London region. Prenat Diagn 2010, 30:509-517.
26. Adinolfi M., Sherlock J. Prenatal detection of chromosome disorders by QF-PCR. Lancet 2001, 358:1030-1031.
27. Quaife R., Wong L.F., Tan S.Y., et al. QF-PCR-based prenatal detection of aneuploidy in a southeast Asian population. Prenat Diagn 2004, 24:407-413.
28. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30:e57.
29. Slater H.R., Bruno D.L., Ren H., Pertile M., Schouten J.P., Choo K.H. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet 2003, 40:907-912.
30. Hochstenbach R., Meijer J., van de Brug J., et al. Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA). Prenat Diagn 2005, 25:1032-1039.
31. Gerdes T., Kirchhoff M., Lind A.-M., Larsen G.V., Schwartz M., Lundsteen C. Computer-assisted prenatal aneuploidy screening for chromosomes 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA). Eur J Hum Genet 2005, 13:171-175.
32. van Opstal D., Boter M., de Jong D., et al. Rapid aneuploidy detection with multiplex ligation-dependent probe amplification: a prospective study of 4000 amniotic fluid samples. Eur J Hum Genet 2009, 17:112-121.
33. Gerdes T., Kirchhoff M., Lind A.-M., Vestergaard Larsen G., Kjaergaard S. Multiplex ligation-dependent probe amplification (MLPA) in prenatal diagnosis - experience of a large series of rapid testing for aneuploidy of chromosomes 13, 18, 21 X, and Y. Prenat Diagn 2008, 28:1119-1125.
34. Kooper A.J., Faas B.H., Kater-Baats E., et al. Multiplex ligation-dependent probe amplification (MLPA) as a stand-alone test for rapid aneuploidy detection in amniotic fluid cells. Prenat Diagn 2008, 28:1004-1010.
35. Kooper A.J., Faas B.H., Feuth T., et al. Detection of chromosome aneuploidies in chorionic villus samples by multiplex ligation-dependent probe amplification. J Molec Diagn 2009, 11:17-24.
36. Boormans E.M., Birnie E., Oepkes D., Galjaard R.-J., Schuring-Blom G.H., van Lith J.M. Mlpa and karyotyping evaluation (M.A.K.E.) study group. Comparison of multiplex ligation-dependent probe amplification and karyotyping in prenatal diagnosis. Obstet Gynecol 2010, 115:297-303.
37. Allen S.K., Luharia A., Gould C.P., MacDonald F., Larkins S., Davison E.V. Rapid prenatal diagnosis of common trisomies: discordant results between QF-PCR analysis and karyotype analysis on long-term culture for a case of trisomy 18 detected in CVS. Prenat Diagn 2006, 26:1160-1167.
38. Waters J.J., Mann K., Grimsley L. Complete discrepancy between QF-PCR analysis of uncultured villi and karyotyping of cultured cells in the prenatal diagnosis of trisomy 21 in three CVS. Prenat Diagn 2007, 27:332-339.
39. Lau E.T., Tang L., Wong C., et al. Assessing discrepant findings between QF-PCR on uncultured prenatal samples and karyotyping on long-term culture. Prenat Diagn 2009, 29:151-155.
40. Mann K., Kabba M., Donaghue C., Hills A., Ogilvie C.M. Analysis of a chromosomally mosaic placenta to assess the cell populations in dissociated chorionic villi: implications for QF-PCR aneuploidy testing. Prenat Diagn 2007, 27:287-289.
41. Hook E.B. Exclusion of chromosomal mosaicism: tables of 90%, 95%, and 99% confidence limits and comments on use. Am J Hum Genet 1977, 29:94-97.
42. Donaghue C., Mann K., Docherty Z., Ogilvie C.M. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis. Prenat Diagn 2005, 25:65-72.
43. Donaghue C., Roberts A., Mann K., Ogilvie C.M. Development and targeted application of a rapid QF-PCR test for sex chromosome imbalance. Prenat Diagn 2003, 23:201-210.
44. Brun J.L., Gangbo F., Wen Z., Galant K., Taine L., Maugey-Laulom B., et al. Prenatal diagnosis and management of sex chromosome aneuploidy: a report on 98 cases. Prenat Diagn 2004, 24:213-218.
45. Levett L.J., Liddle S., Meredith R. A large-scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy. Ultrasound Obstet Gynecol 2001, 17:115-118.
46. Badenas C., Rodríguez-Revenga L., Morales C., et al. Assessment of QF-PCR as the first approach in prenatal diagnosis. J Molec Diagn 2010, 12:828-834.
47. Grimshaw G.M., Szczepura A., Hulten M., et al. Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 2003, 7(10).
48. Caine A., Maltby A.E., Parkin C.A., Waters J.J., Crolla J.A. UK Association of Clinical Cytogeneticists (ACC). Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18 and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 2005, 366:123-128.
49. Wolstenholme J. Prenatal DNA diagnosis of Down's syndrome by PCR. Lancet 1998, 352:989-990.
50. Ogilvie C.M. Prenatal diagnosis for chromosome abnormalities: past, present and future. Pathol Biol 2003, 51:156-160.
51. Wenstrom K.D. Aneuploidy screening: the changing scene. Obstet Gynecol 2003, 101:840-842.
52. Chitty L.S., Kagan K.O., Molina F.S., Waters J.J., Nicolaides K.H. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study. BMJ 2006, 332:452-455.
53. Kagan K.O., Chitty L.S., Cicero S., Eleftheriades M., Nicolaides K.H. Ultrasound findings before amniocentesis in selecting the method of analysing the sample. Prenat Diagn 2007, 27:34-39.
54. Boormans E.M.A., Birnie E., Oepkes D., et al. The impact of rapid aneuploidy detection (RAD) in addition to karyotyping versus karyotyping on maternal quality of life. Prenat Diagn 2010, 30:425-433. on behalf of the M.A.K.E. Study Group.